When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Alzheimer disease

Last reviewed: 22 Nov 2024
Last updated: 05 Sep 2023

Summary

Definition

History and exam

Key diagnostic factors

  • memory loss
  • disorientation
  • nominal dysphasia
  • misplacing items/getting lost
  • apathy
  • decline in activities of daily living and instrumental activities of daily living (IADLs)
  • personality change
  • unremarkable initial physical exam
Full details

Other diagnostic factors

  • mood changes
  • poor abstract thinking
  • constructional dyspraxia
  • prosopagnosia
  • autoprosopagnosia
Full details

Risk factors

  • advanced age
  • family history
  • genetics
  • Down syndrome
  • cerebrovascular disease
  • lifestyle factors and medications
  • less than high school education
  • traumatic brain injury
  • depression
  • hearing loss
  • hyperlipidemia
  • female sex
  • elevated plasma homocysteine level
  • artificially sweetened soft drink consumption
Full details

Diagnostic tests

1st tests to order

  • bedside cognitive testing
  • CBC
  • metabolic panel
  • serum thyroid-stimulating hormone (TSH)
  • serum vitamin B12
  • urine drug screen
  • CT
  • MRI
Full details

Tests to consider

  • cerebrospinal fluid (CSF) analysis
  • serum rapid plasma reagin/Venereal Disease Research Laboratory (VDRL)
  • serum HIV
  • formal neuropsychological testing
  • genetic testing
  • fluorodeoxyglucose-PET (FDG-PET)
  • single-photon emission CT (SPECT)
  • electroencephalogram (EEG)
Full details

Emerging tests

  • amyloid-PET

Treatment algorithm

ONGOING

all patients

Contributors

Authors

Judith Neugroschl, MD

Associate Professor of Psychiatry

Alzheimer's Disease Research Center

Icahn School of Medicine at Mount Sinai

New York

NY

Disclosures

JN participates in research funded by National Institutes for Health (NIH) grants. The Alzheimer's Disease Research Center is a site for clinical research but JN is not the site Principal Investigator, has no role in purchasing nor choosing the studies, and gains no compensation if they succeed. JN helps to edit the Focus on Healthy Aging Alzheimer's yearly report.

Acknowledgements

Dr Judith Neugroschl would like to gratefully acknowledge Dr Brandy R. Matthews, Dr Asif S. Bhutto, and Dr Julie K. Gammack, the previous contributors to this topic.

Disclosures

BRM, ASB, and JKG declare that they have no competing interests.

Peer reviewers

Roy J. Goldberg, MD, FACP, AGSF, CMD

Medical Director

Kings Harbor Multicare Center

New York

NY

Disclosures

RJG declares that he has no competing interests.

Philip Scheltens, MD, PhD

Professor of Neurology

Department of Neurology/Alzheimer Center

VU University Medical Center

Amsterdam

The Netherlands

Disclosures

PS declares that he has no competing interests.

  • Differentials

    • Delirium
    • Depression
    • Vascular dementia
    More Differentials
  • Guidelines

    • Clinical guidance in neuropalliative care: an AAN position statement
    • Ethical considerations in dementia diagnosis and care: an AAN position statement
    More Guidelines
  • Patient information

    Alzheimer disease and other kinds of dementia

    Alzheimer disease and other kinds of dementia: what treatments work?

    More Patient information
  • Calculators

    Geriatric Depression Scale

    More Calculators
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer